These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17895124)

  • 41. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CLOTBUST: design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke.
    Alexandrov AV; Wojner AW; Grotta JC;
    J Neuroimaging; 2004 Apr; 14(2):108-12. PubMed ID: 15095554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience.
    Lattimore SU; Chalela J; Davis L; DeGraba T; Ezzeddine M; Haymore J; Nyquist P; Baird AE; Hallenbeck J; Warach S;
    Stroke; 2003 Jun; 34(6):e55-7. PubMed ID: 12750543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emergency medicine residents in the implementation of thrombolysis for acute ischemic stroke.
    Hälinen M; Mattila K; Janhunen H
    Duodecim; 2016; 132(24):2342-48. PubMed ID: 29199794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.
    Graham GD
    Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience.
    Koennecke HC; Nohr R; Leistner S; Marx P
    Stroke; 2001 May; 32(5):1074-8. PubMed ID: 11340212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombolysis in acute childhood stroke: design and challenges of the thrombolysis in pediatric stroke clinical trial.
    Amlie-Lefond C; Chan AK; Kirton A; deVeber G; Hovinga CA; Ichord R; Stephens D; Zaidat OO;
    Neuroepidemiology; 2009; 32(4):279-86. PubMed ID: 19223687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved time intervals by implementation of computerized physician order entry-based stroke team approach.
    Nam HS; Han SW; Ahn SH; Lee JY; Choi HY; Park IC; Heo JH
    Cerebrovasc Dis; 2007; 23(4):289-93. PubMed ID: 17199086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.
    Haršány M; Tsivgoulis G; Alexandrov AV
    Expert Rev Neurother; 2014 Aug; 14(8):879-92. PubMed ID: 24984941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke.
    Kim AS; Nguyen-Huynh M; Johnston SC
    Stroke; 2011 Jul; 42(7):2013-8. PubMed ID: 21636817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Views of emergency physicians on thrombolysis for acute ischemic stroke.
    Bobrow BJ; Demaerschalk BM; Wood JP; Villarin A; Clark L; Jennings A
    J Brain Dis; 2009; 1():29-37. PubMed ID: 23818807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
    Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
    Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.
    Barber PA; Zhang J; Demchuk AM; Hill MD; Buchan AM
    Neurology; 2001 Apr; 56(8):1015-20. PubMed ID: 11320171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thromobolysis for acute ischemic stroke: is intra-arterial better than intravenous? A treatment effects model.
    Powers WJ
    J Stroke Cerebrovasc Dis; 2012 Jul; 21(5):401-3. PubMed ID: 22464277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.